EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT)

Historical Holders from Q4 2020 to Q3 2025

Symbol
EYPT on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
82,815,631
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
69,367,962
Holdings value
$987,669,513
% of all portfolios
0.003%
Number of holders
147
Number of buys
68
Number of sells
-62
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 9.98% $99,097,350 8,265,000 Cormorant Asset Management, LP 04 Dec 2025
Adage Capital Management, L.P. 8.07% -18.1% $79,171,296 -$17,660,704 5,559,782 -18.2% Adage Capital Management, L.P. 30 Sep 2025
FEDERATED HERMES, INC. 6.68% $43,281,744 4,599,450 Federated Hermes, Inc. 30 Jun 2025
BlackRock, Inc. 6.5% $63,872,124 4,485,402 BlackRock, Inc. 30 Sep 2025
FRANKLIN RESOURCES INC 6.1% -17.5% $27,059,688 +$820,894 4,137,567 +3.1% Franklin Resources, Inc. 31 Dec 2024
RA CAPITAL MANAGEMENT, L.P. 4.7% $20,809,090 3,181,818 RA Capital Management, L.P. 31 Dec 2024

Institutional Holders of EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 69,367,962 $987,669,513 +$20,151,563 $14.24 147
2025 Q2 68,912,118 $648,484,078 -$21,934,653 $9.41 139
2025 Q1 74,070,140 $401,203,753 -$6,558,607 $5.42 149
2024 Q4 74,299,852 $553,357,101 +$114,467,368 $7.45 141
2024 Q3 58,498,731 $476,138,776 -$4,424,916 $7.99 135
2024 Q2 58,415,381 $508,206,601 -$17,769,473 $8.7 148
2024 Q1 55,009,467 $1,137,046,639 +$106,318,844 $20.67 161
2023 Q4 49,565,894 $1,145,491,759 +$422,510,894 $23.11 138
2023 Q3 33,709,262 $269,337,991 +$16,845,118 $7.99 98
2023 Q2 31,573,084 $274,685,383 +$22,852,995 $8.7 82
2023 Q1 29,111,970 $85,592,348 -$1,206,242 $2.94 66
2022 Q4 29,377,926 $102,818,972 -$13,441,865 $3.5 72
2022 Q3 30,106,241 $238,140,639 -$883,849 $7.91 82
2022 Q2 30,200,779 $237,683,742 -$3,357,027 $7.87 78
2022 Q1 30,440,222 $369,919,357 +$7,173,181 $12.15 78
2021 Q4 29,839,293 $365,363,130 +$94,551,507 $12.24 83
2021 Q3 22,128,108 $230,547,815 +$14,765,407 $10.42 61
2021 Q2 20,739,059 $186,447,743 +$7,944,014 $8.99 59
2021 Q1 19,642,118 $199,571,620 +$124,369,380 $10.16 58
2020 Q4 7,703,318 $50,684,935 +$50,684,935 $6.58 31